Study Information

What’s involved?

  • 5 days & nights inpatient stay
  • 1 quick follow-up appointments

Participants will be reimbursed $2,050 for participating in this study and this clinical trial has been approved by an independent ethics committee.

About the study

This study is investigating a medication designed to increase the activity of certain immune system cells, called T cells. T cells are a type of white blood cell involved in the body’s response to infection and disease. By increasing the effectiveness of these T cells the medication is hoped to improve the immune systems ability to target and eliminate cancer.

How do I find out more?

If you have already registered with us but would like more information about this study, please call 1800 243 733 or schedule a call back. You can also email us at reply@clinicalstudies.com.au quoting “White Cell Study”.

If you are interested in participating and have not previously registered as a participant with us, fill in your details in the form below and we’ll be in touch soon!

  • 5
    Nights Inpatient Stay
  • 1
    Outpatient Visit

Minimum Eligibility Requirements:

  • Healthy Males and Females
  • Aged 18 - 55
  • Body Mass Index (BMI) 18 – 32kg/m²
  • No medical conditions
  • Must not have smoked 1 month prior to the study commencement
Top